entertainment -WSS

entertainment

author：explore 2025-10-02 19:20:58 - browse：99

Adam's take main illustration — Molly Ferguson/STAT

Have you heard the news? I’m launching a weekly email newsletter starting on March 28. It’s called Adam’s Biotech Scorecard and it’s exclusively for STAT subscribers. One catch: We need you to sign up, which you can do here. What should you expect to see in my newsletter each week? Unfiltered, uncompromising, and (hopefully) valuable insight and analysis from the intersection of Wall Street and biotech. Plus, a few dashes of fun.

In other words, a lot like the content below. I’m really excited to get started and I hope you’ll find the newsletter worthy of your inbox real estate.

This week: A deep dive into the bull and bear sides of the Applied Therapeutics debate, and another well-deserved swipe at Cassava Sciences and its entirely ridiculous Alzheimer’s drug candidate.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Sepsis can kill a child within hours. Here's how hospitals are fighting back

hotspot

entertainment

WSS

With fresh data, a dynamic duo powers Eli Lilly to new heights

Has Bernie Sanders reached the limit of his pharma bullying effort?

BIO to announce reorganization, senior leaders expected to depart

Titanic submersible victims' family mourns: 'Enormous tragedy and devastation'

The effects of a landmark ruling on DNA ownership are becoming clearer

US intelligence assessment says Iran not currently developing nuclear weapons

explore

entertainment

hotspot

Medicare proposal to cover medical devices draws a mixed reaction

Readout Newsletter: PTC, Dyne, Rapport, Cytokinetics news

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Lawmakers grill UnitedHealth CEO on Change cyberattack

DIEP, the 'gold standard' of breast reconstruction, is under threat

North Korean leader's powerful sister says warplanes repelled US spy plane

Novavax promises a turnaround & Lilly roils the obesity market

BIO to announce reorganization, senior leaders expected to depart

The cancer drug shortage isn’t new — and neither are the solutions

AltruBio raises $225 million to develop ulcerative colitis drug

hotspot

Warren pushes Witty on UnitedHealth's control over physicians

Titanic submersible: What a 'catastrophic implosion' means and what officials found

Primary care doctor shortage won't be solved by free med school tuition

As health system earnings go up, health insurance stocks go down

GSK’s asthma push continues as drug succeeds in Phase 3 trials

AI for drug discovery: Experts on separating hype from reality

hotspot

entertainment

leisure time

explore